- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.03. | WuXi AppTec offers rosy 2025 guidance despite threat of US-China trade tensions | ||
| 18.03. | IRA round 2 begins as drugmakers sign on to price negotiation process with CMS | ||
| 18.03. | Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program | ||
| 18.03. | Sarepta reports 1 death after patient received DMD gene therapy Elevidys | ||
| 18.03. | Novartis plans 427 layoffs in New Jersey as looming Entresto patent cliff sparks marketing refresh | ||
| 17.03. | Dr. Reddy's, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues | ||
| 17.03. | Merck plots 163 layoffs as it prepares to shutter Pennsylvania manufacturing site | ||
| 17.03. | AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama | ||
| 17.03. | Novo Nordisk accepted back into UK pharma group after 'sustained improvements' get suspension lifted | ||
| 14.03. | Roche settles UPenn suit alleging patent infringement by Herceptin, 3 other breast cancer meds | ||
| 14.03. | AstraZeneca recruits sportscaster Erin Andrews to join hockey-themed cancer screening campaign | ||
| 14.03. | Senators expand probe of Pfizer, Lilly DTC platforms to include telehealth provider partners | ||
| 14.03. | UK lifts drug rebate rate as pharma industry decries 'fundamentally broken' market | ||
| 14.03. | In rebound year for Pfizer, CEO Albert Bourla scored 14% total pay increase to $24.6M | ||
| 14.03. | FDA chief counsel Hilary Perkins hits the exit, resigning amid controversy two days into the job | ||
| 14.03. | FBI and other agencies investigate fire at Bayer executive's New Jersey home: reports | ||
| 13.03. | AstraZeneca embraces pickleball trend with Fasenra tour sponsorship, themed DTC ad | ||
| 13.03. | Amid Vafseo's US launch, Akebia plots phase 3 study to grow CKD anemia med's reach | ||
| 13.03. | Mallinckrodt, Endo look to carve out brighter future through $6.7B merger | ||
| 13.03. | NFL drafts Novartis as league's first corporate pharma partner | ||
| 13.03. | Zevra Therapeutics embarks on diagnosis push as Miplyffa launch gains steam | ||
| 12.03. | Moderna CEO Stéphane Bancel scored pay bump in 2024 despite revenue decline and missed sales target | ||
| 12.03. | J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms | ||
| 12.03. | Argenx's Vyvgart tops Trinity's latest launch success analysis, beating out several Big Pharma debuts | ||
| 12.03. | AbbVie regained TV ad spending lead amid February slowdown, with Rinvoq and Skyrizi back on top |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
